Atyr PHARMA (ATYR) Institutional Ownership $3.26 +0.02 (+0.62%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$3.32 +0.07 (+1.99%) As of 03/27/2025 06:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Atyr PHARMA (NASDAQ:ATYR)CurrentInstitutional OwnershipPercentage61.72%Number ofInstitutional Buyers(last 12 months)48TotalInstitutional Inflows(last 12 months)$121.39MNumber ofInstitutional Sellers(last 12 months)0 Get ATYR Insider Trade Alerts Want to know when executives and insiders are buying or selling Atyr PHARMA stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ATYR Institutional Buying and Selling by Quarter Remove Ads Atyr PHARMA Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/27/2025Jefferies Financial Group Inc.55,600$201K0.0%N/A0.066% 2/18/2025 Alpine Global Management LLC17,429$63K0.0%N/A0.021% 2/17/2025 Woodline Partners LP1,683,000$6.09M0.0%N/A2.005% 2/17/2025 Squarepoint Ops LLC26,614$96K0.0%N/A0.032% 2/17/2025 Two Sigma Advisers LP12,250$44K0.0%N/A0.015% 2/17/2025 Two Sigma Investments LP21,628$78K0.0%N/A0.026% 2/17/2025 Tang Capital Management LLC671,134$2.43M0.2%N/A0.800% 2/17/2025 Stempoint Capital LP200,475$726K0.2%N/A0.239% 2/17/2025 Point72 Asset Management L.P.4,883,197$17.68M0.0%N/A5.817% 2/17/2025 Man Group plc15,248$55K0.0%N/A0.018% Get the Latest News and Ratings for ATYR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atyr PHARMA and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 OMERS ADMINISTRATION Corp138,000$500K0.0%N/A0.164% 2/17/2025 Octagon Capital Advisors LP900,000$3.26M0.5%N/A1.072% 2/17/2025 Millennium Management LLC367,989$1.33M0.0%N/A0.438% 2/17/2025 Integral Health Asset Management LLC375,000$1.36M0.1%N/A0.447% 2/17/2025 J. Goldman & Co LP300,131$1.09M0.0%N/A0.358% 2/17/2025Jefferies Financial Group Inc.55,600$201K0.0%N/A0.066% 2/17/2025 Group One Trading LLC7,240$26K0.0%N/A0.009% 2/17/2025 Balyasny Asset Management L.P.44,310$160K0.0%N/A0.053% 2/17/2025 Bank of America Corp DE91,224$330K0.0%N/A0.109% 2/17/2025 Alyeska Investment Group L.P.1,278,441$4.63M0.0%N/A1.523% 2/17/2025 Ally Bridge Group NY LLC699,730$2.53M2.1%N/A0.834% 2/17/2025 683 Capital Management LLC248,000$898K0.1%N/A0.295% 2/14/2025 Jane Street Group LLC199,006$720K0.0%N/A0.237% 2/14/2025 Schonfeld Strategic Advisors LLC63,635$230K0.0%N/A0.076% 2/14/2025 Northern Trust Corp182,625$661K0.0%N/A0.218% 2/14/2025 Oxford Asset Management LLP31,784$115K0.1%N/A0.038% 2/14/2025 Boothbay Fund Management LLC14,568$53K0.0%N/A0.017% 2/14/2025 Adage Capital Partners GP L.L.C.1,000,000$3.62M0.0%N/A1.191% 2/14/2025 Alpine Global Management LLC17,429$63K0.0%N/A0.021% 2/14/2025 Tower Research Capital LLC TRC 32,856$119K0.0%N/A0.039% 2/14/2025 Dimensional Fund Advisors LP243,369$881K0.0%N/A0.290% 2/13/2025 XTX Topco Ltd11,182$40K0.0%N/A0.013% 2/13/2025 Barclays PLC159,407$577K0.0%N/A0.190% 2/13/2025 Raymond James Financial Inc.10,694$39K0.0%N/A0.013% 2/13/2025 Renaissance Technologies LLC574,455$2.08M0.0%N/A0.684% 2/13/2025 Federated Hermes Inc.14,666,600$53.09M0.1%N/A17.473% 2/13/2025 Tikvah Management LLC2,460,833$8.91M2.5%N/A2.932% 2/13/2025 Wells Fargo & Company MN105,769$383K0.0%N/A0.126% 2/12/2025 ExodusPoint Capital Management LP16,786$61K0.0%N/A0.020% 2/12/2025 Knott David M Jr308,133$1.12M0.4%N/A0.367% Trump Makes Major Crypto Announcement (Ad)Trump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to all investors right now.Click here to check it out now2/12/2025 Geode Capital Management LLC891,407$3.23M0.0%N/A1.062% 2/12/2025 Diametric Capital LP29,812$108K0.1%N/A0.036% 2/12/2025 JPMorgan Chase & Co.178,532$646K0.0%+467.8%0.213% 2/11/2025 American Century Companies Inc.88,112$319K0.0%N/A0.105% 2/10/2025 Farther Finance Advisors LLC24,423$88K0.0%N/A0.029% 2/6/2025 Raymond James Financial Inc.10,694$39K0.0%N/A0.013% 2/6/2025 Victory Capital Management Inc.10,138$37K0.0%N/A0.012% 2/6/2025 Charles Schwab Investment Management Inc.39,689$144K0.0%N/A0.047% 1/31/2025 D.A. Davidson & CO.39,000$141K0.0%N/A0.046% 1/24/2025 Alterna Wealth Management Inc.10,000$36K0.0%N/A0.012% 1/22/2025 Kingswood Wealth Advisors LLC47,000$170K0.0%N/A0.056% 1/1/2025 JPMorgan Chase & Co.31,440$55K0.0%+52.0%0.037% (Data available from 1/1/2016 forward)Remove Ads ATYR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ATYR shares? During the previous two years, 48 institutional investors and hedge funds held shares of Atyr PHARMA. The most heavily invested institutionals were Federated Hermes Inc. ($53.09M), Point72 Asset Management L.P. ($17.68M), Tikvah Management LLC ($8.91M), Woodline Partners LP ($6.09M), Alyeska Investment Group L.P. ($4.63M), Adage Capital Partners GP L.L.C. ($3.62M), and Octagon Capital Advisors LP ($3.26M).Learn more on ATYR's institutional investors. What percentage of Atyr PHARMA stock is owned by institutional investors? 61.72% of Atyr PHARMA stock is owned by institutional investors. Learn more on ATYR's institutional investor holdings. Which institutional investors have been buying Atyr PHARMA stock? Of the 48 institutional investors that purchased Atyr PHARMA stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Federated Hermes Inc. ($14.67M), Point72 Asset Management L.P. ($4.88M), Tikvah Management LLC ($2.46M), Woodline Partners LP ($1.68M), Alyeska Investment Group L.P. ($1.28M), Adage Capital Partners GP L.L.C. ($1M), and Octagon Capital Advisors LP ($900K). How much institutional buying is happening at Atyr PHARMA? Institutional investors have bought a total of 33,539,492 shares in the last 24 months. This purchase volume represents approximately $121.39M in transactions. Related Companies Adaptive Biotechnologies Major Shareholders Evotec Major Shareholders ARS Pharmaceuticals Major Shareholders Ardelyx Major Shareholders Ocular Therapeutix Major Shareholders Structure Therapeutics Major Shareholders Calliditas Therapeutics AB (publ) Major Shareholders Iovance Biotherapeutics Major Shareholders Syndax Pharmaceuticals Major Shareholders Aurinia Pharmaceuticals Major Shareholders This page (NASDAQ:ATYR) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atyr PHARMA INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Atyr PHARMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.